baber/WOPTO huggingface dataset:
Patent CZ-286400-B6 (CZ)
Title: Heterocyclyl benzoylguanidine, process of its preparation and pharmaceutical preparation containing thereof
Inventor: GERICKE ROLF DR
IPC: C07D295/155
Filed: 1995-08-29
Abstract: In the present invention there is disclosed a heterocyclylbenzoyl guanidine of the general formula I, in which Re1 represents A, CFi3, CHi2F, CHFi2, Ci2Fi5, CN, NOi2, Hal, C=CH or -X-Re4, Re2 and Re3 represent independently on each other hydrogen Hal, A, -Y-Re4, CN, NOi2, CFi3, CHi2F, CHFi2, Ci2Fi5, CHi2CFi3, -SOin-Re6 or -SOi2NRe4Re5, Ph or OPh, Re5H, A cycloalkyl containing 5 to 7 carbon atoms cycloalkyl methyl containing 6 to 8 carbon atoms  in the cycloalkyl moiety, Cfi3, CHi2F, CHFi2, CHi2CFi3, Ph or -CHi2-Ph, Re5H or A, however Re4 and Re5 together form also alkylene containing 4 to 5 carbon atoms, whereby one CHi2 group can also be substituted with oxygen, sulfur, NH, N-A or N-CHi2-Ph, Re6A or Ph, Het imidazolyl, piperidinyl, pyrazolyl, dihydropyridyl, pyrrolyl, benzimidazolyl or furanyl being optionally substituted with 1 or 2 substituents that are selected from a group comprising OH, NHi2, A and/or an oxo group, alkyl containing 1 to 6 carbon atoms, Hal fluorine, chlorine, bromine or iodine, XO, sulfur or NRe5, Ph phenyl being optionally substituted with one, two or three substituents that are selected from a group comprising A, OA, NRe4Re5, fluorine, chlorine, bromine, iodine or trifluoromethyl, n is 1 or 2, as well as physiologically acceptable salts. All the aforementioned compounds exhibit anti-arrhythmic properties and act as inhibitors of cellular Nae+/He+ antiporter.
Patent CZ-291681-B6 (CZ)
Title: Imidazopyridine derivative, process of its preparation and use as well as pharmaceutical preparation in which the derivative is comprised
Inventor: AMIN KOSRAT
IPC: C07D471/04
Filed: 1998-02-17
Abstract: The present invention relates to imidazopyridine derivatives of the general formula I, in which the phenyl radical is substituted with an alkyl group in position 2, and their pharmaceutically acceptable salts, as well as their use in prophylaxis and treatment of gastrointestinal inflammatory diseases. The invented derivatives inhibit exogenously and endogenously stimulated secretion of stomach acid.
Patent SK-284731-B6 (SK)
Title: Indazole amide compound, process for producing it, intermediate product for its preparation and pharmaceutical composition containing it
Inventor: ALISI ALESSANDRA
IPC: A61P25/00
Filed: 1998-04-02
Abstract: Indazole amide compound having general formula (I) wherein R6 is selected from the group comprising (C3-C7)cycloalkyl, heterocyclic ring having from 5 or 6 members where 1 to 4 are heteroatoms, the same or different from each other, selected from the group comprising N, O and S, dimethylamino-(C1-C3)alkyl, methoxy-(C1-C3)alkyl, N-phenyl amide, aminosulphonylmethyl, dihydroxy-(C2-C3)alkyl or phenyl, naphthyl or biphenyl group, which are substituted by hydroxy, acid addition salts thereof with pharmaceutically acceptable organic and inorganic acids and pharmaceutically acceptable quaternary salts thereof. Also is described multistep process for preparing this compound, as well as intermediate product using in it and pharmaceutical composition containing indazole amide compound having general formula (I).
Patent SK-278020-B6 (SK)
Title: Parallel guiding of magnets of rail brake, rail magnetic braking unit located in rail vehicles
Inventor: LACHMANN KLAUS
IPC: B61H7/00
Filed: 1992-12-02
Abstract: Parallel guiding is equipped under pendant elements (2, 2') with elastic seating (6), which is created with yoke (6a) and laterally located rubber dumping buffer (6b). Yoke (6a) grips the auxiliary frame (7) which is by its own ends supported always on one axis of undercarriage auxiliary frame (7) is with the tension spring (9) which is located by yoke (6a) elastic holded towards longitudinal beam (10) in stabil position. Own limiting of auxiliary frame (7) towards longitudinal carrier (10) of frame towards swively undercarriage is flattened with laterally located sliding buffer (13).
Patent SK-278234-B6 (SK)
Title: Sealing shutter for a shaft furnace
Inventor: LONARDI EMILE
IPC: F27B1/20
Filed: 1989-12-21
Abstract: A SHAFT FURNACE CHARGE CLOSING A shaft furnace charge closing, created with a closing flap (16) of a charging throat (12) of a charging hooper (14), and an annular saddle (24) of a fixed hooper discharge opening (26) of a charge bin (10), of which sealing bin gate (20) is arranged movably between closing position in which is in contact with the annular saddle and opening position out of the discharge opening, wherein the annular saddle (24) comprises an inside channel (28) joined with a circuit of liquid with a temperature regulating mechanism.
Patent CZ-302386-B6 (CZ)
Title: Propagation medium for cultivating thermotolerant Campylobacter sp. strains
Inventor: SKRIVANOVA EVA
IPC: C12N1/20
Filed: 2010-07-14
Abstract: The present invention relates to a propagation medium for cultivating thermotolerant Campylobacter sp. strains being characterized in that the main component thereof is L-glutamic acid in an amount of 3 to 10 g, wherein it further contains 3 to 10 g of acid casein hydrolysate, 0.5 to 3 g peptone water, 0.2 to 2 ml mineral aqueous solution, 1 to 3 ml of an agent A containing iron oxide salt, sodium metabisulfite and sodium pyruvate, 1 to 3 ml of an agent B containing trimethoprim, polymyxin, rifampicin and cycloheximide, and the remainder up to the 500 ml of the medium being added with distilled water.
Patent CZ-304728-B6 (CZ)
Title: Lamellas mount, especially for exterior louverall sun breaker
Inventor: BOSÁK DALIBOR
IPC: E06B7/084
Filed: 2013-02-22
Abstract: The present invention relates to a mount (1), particularly for exterior louverall sun breakers, consisting of segments (11, 12) inserted in each other. The external segment (11) and the internal segment (12) are hinged in such a manner that the concave contact surface (115) of the external segment (11) encompasses the convex contact surface (125) of the internal segment (12) and at the same time external segment (11) and the internal segment (12) are pressed to each other by means of a clamping bolt (7) that produces a required overstressing. The external segment (11) is attached to the supporting structure (3) while the internal segment (12) is coupled with a screening profile (2). The external segment (11) of the mount (1) is formed by a flat base (111) with a pressure arm (112) and seat arm (113) projecting therefrom in such a way that first an assembly slot (114) is formed therebetween and then they open in a bend-like manner forming thus the common internal concave contact surface (115). At the end portions of the concave contact surface (115), the arms (112) and (113) are provided with a centerwards extending catching claws (116) insertable in at least two catching grooves (126) performed on the convex contact surface (125) of the internal segment (12), and namely in two opposite systems.
Patent SK-286670-B6 (SK)
Title: Container with a sealed insert, and pump for opening said sealing
Inventor: KNEER ROLAND
IPC: B65D/
Filed: 1998-08-21
Abstract: In the neck (2) of container (1) is arranged a pump device (6) for delivering a liquid container content. On inner wall of the neck (2) of the container (1) there a substantially tubular insert (3), which has a base (5) which is closed in an initial state, whereby before putting the pump device (6) into operation, by advancing a front suction of the pump device (6), which engaged in the insert (3) and whose peripheral wall (27) closely engages the inner wall of the insert (3), the base (5) is opened by direct contact with the suction section. A receiving chamber (15) for an active substance, which is separated from the liquid container (1) content before the opening of the base (5) and enters into it after opening process, is arranged inside the insert (3) above it's the base (5).
Patent CZ-296425-B6 (CZ)
Title: Molluse stomach poison composition enhanced with ethylene diamine disuccinic acid
Inventor: PURITCH GEORGE S
IPC: C05G3/60
Filed: 1999-02-04
Abstract: In the present invention, there is disclosed an ingestible mollusk poison containing a simple metal compound, an activity enhancing additive such as ethylene diamine disuccinic acid (EDDS) and derivatives thereof, and a carrier material edible to mollusks. In one embodiment, the active agent of the mollusk poison may be in the form of a metal complex of EDDS. The composition may be used alone or in conjunction with molluscicidal co-active agents and/or fertilizers. Further described is a method of exterminating unwanted mollusk pests.
Patent CZ-301851-B6 (CZ)
Title: Method for stabilizing pharmaceutical compositions by special use of an antioxidant
Inventor: KIS GYOERGY LAJOS
IPC: A61K9/08
Filed: 1999-03-31
Abstract: In the present invention, there is disclosed a method for the stabilization of an aqueous pharmaceutical composition characterized by contacting said composition with a polymeric material being selected from the group consisting of polyethylene, polypropylene and a mixture thereof, comprising an antioxidant incorporated into the polymeric material and being selected from the group consisting of 2,2', 2", 6,6', 6"-hexa-(1, 1-dimethylethyl)-4,4', 4"- [(2,4,6-trimethyl-1,3,5-benzenetriyl)-trismethylene]-triphenol (Irganox 1330), 1,3,5, tris [3,5-di(1,1-dimethylethyl)-4-hydroxybenzyl]1 H, 3H, 5H-1,3,5-triazine-2,4,6-trione, pentaerythrityl tetrakis [3- [3, 5-di (1,1-dimethylethyl)-4hydroxyphenyl]-propionate], octadecyl-3- [3,5-di (1,1-dimethylethyl)-4-hydroxyphenyl]propionate, tris [2,4-di (1,1-dimethylethyl)-phenyl]-phosphite, 2,2'-di (octa-decyloxy)-5,5'spirobi (1,3,2-dioxaphosphorinane), dioctadecyl disulphide, didodecyl-3, 3'-thiodipropionate, dioctadecyl-3,3'-thiodipropionate, butylhydroxytoluene, ethylene bis [3,3-di [3- (1,1- dimethylethyl)-4-hydroxyphenyl] butyrate], and mixtures thereof wherein the polymeric material is insoluble in said pharmaceutical composition.
Patent CZ-301017-B6 (CZ)
Title: Medicament for reducing risk of vertebral or non-vertebral bone fracture in human and risk of osteoporosis
Inventor: HOCK JANET M
IPC: A61K38/22
Filed: 1999-08-19
Abstract: In the present invention, there is disclosed the use of a parathyroid hormone containing amino acid sequence 1 - 34 of human parathyroid hormone for preparing medicaments to reduce risk of vertebral or non-vertebral bone fracture in human and risk of osteoporosis, when parathyroid hormone is administered to the subject without concurrent administering of anti-resorption agent different than vitamin D or calcium, in daily dosage from 20 micrograms.
Patent CZ-304118-B6 (CZ)
Title: Pharmaceutical composition
Inventor: ALANI LAMAN
IPC: A61P43/00
Filed: 2000-12-01
Abstract: In the present invention, there are provided improved pharmaceutical compositions comprising a solution containing a) (2S,3S,5S)-5-(N-(N-methyl-N-((2-isopropyl-4-thiazolyl)-methyl)amino)carbonyl-L-valinyl)amino-2-(N-((5-thiazole)-methoxycarbonyl)amino)-1,6-diphenyl-3-hydroxyhexane, (ritonavir); b) a pharmaceutically acceptable organic solvent comprising (i) a pharmaceutically acceptable medium and/or long chain fatty
Patent CZ-299463-B6 (CZ)
Title: Recognition method of radioactive beta particles
Inventor: HAVRANEK MILOUE
IPC: G01T1/38
Filed: 2002-12-18
Abstract: Different energy of beta rays originating from hydrogen e3H, carbon e14C and phosphorus e32P, being manifested in their different penetration capacity in air is used for recognition of some radioactive beta rays (electrons). We compare two beta radiators, each providing approximately + pulse per second. Measuring probes are situated at different distances (heights) depending on different energies of the beta rays, above a radioactivity source. During experiment, a coincidence of the beta rays originating from different radionuclides is monitored. By recording of all indispensable data into a laboratory record, denomination of some beta rays (electrons) is obtained. There is also determined, that a time history (i.e. ôbirthö and ôextinctionö) of the individual beta rays (electrons) is not identical.
Patent CZ-298607-B6 (CZ)
Title: Expandable styrene polymers containing carbon particles
Inventor: GLUECK GUISCARD
IPC: C08K3/04
Filed: 2002-01-11
Abstract: The present invention relates to expandable particulate styrene particles that contain graphite particles or carbon black particles and, as expanding agents, 2.2 to 6 percent by weight of pentane and 1 to 10 percent by weight of water.
Patent CU-23538-B7 (CU)
Inventor: GARACI ENRICO
IPC: A61P25/00
Filed: 2004-12-16
Abstract: The present invention refers to pharmaceutical preparations including as active compounds 3-aza-bicyclo[3.2.1]octane derivatives of general formula (I) and/or their dimers of general formula (II) and (III) acting as agonists of human neurotrophines. Therefore, such compounds of formula (I), (II) and (III) are useful for treatment of diseases in which the neurotrophine functions are involved in defect, particularly of Nerve Growth Factor (NGF), such as neurodegenerative diseases of central nervous system (CNS), acquired immunodeficiency due to a reduced NGF biodisponibility, or morbous conditions in which the stimulus of neoangiogenesis process is convenient.
Patent BR-PI0309769-B8 (BR)
Title: composição lubrificante substancialmente anidra
Inventor: NAWAZ AHMAD
IPC: A61P15/00
Filed: 2003-05-01
Abstract: "composições lubrificantes de aquecimento e não-irritantes e método de comparação de irritação". a presente invenção refere-se a composições lubrificantes não-tóxicas e não-irritantes, de aquecimento substancialmente anidras, contendo álcoois poliídricos e um agente de isolamento. a invenção refere-se também a método de uso de tais composições para lubrificação, administração de ingredientes ativos e para prevenção ou tratamento de dismenorréia.
Patent GB-2413764-B8 (GB)
Title: Anthelmintic compostion
Inventor: LAU KAI KIN
IPC: A61K31/167
Filed: 2004-02-04
Granted: 2013-10-16
Abstract: The invention relates to the treatment of anthelmintic infections in animals, and more particularly to compositions that are effective against parasites that are resistant to a wide variety of drug treatments. In a first aspect, the invention provides a synergistic anthelmintically effective composition consisting of at least one compound selected from each of the following groups: macrocylic lactones, benzimidazoles, salicylanilides and imidazothiazoles and a therapeutically acceptable carrier. In a second aspect, the invention provides a method for treating parasitic infections in an animal, comprising administering to the animal, a synergistic anthelmintically effective amount of a composition which consists of at least one compound selected from each of the following groups: macrocylic lactones, benzimidazoles, salicylanilides and imidazothiazoles and a therapeutically acceptable carrier. In a third aspect, the invention provides the use of a synergistic anthelmintically effective amount of a composition which consists of at least one compound selected from each of the following groups: macrocylic lactones, benzimidazoles, salicylanilides and imidazothiazoles and a therapeutically acceptable carrier in the treatment of a parasitic infection in an animal.
Patent EP-1553796-B8 (EP)
Inventor: XUE HAO
IPC: H04W4/00
Filed: 2004-01-12
Granted: 2010-03-24
Abstract: A method and system of providing a mobile data device in a wireless system with information about preferred networks to connect to, the mobile data device having a preferred roaming list with a list of networks, the method comprising the steps of: adding to the preferred roaming list information about whether each network in the list of networks supports third generation data capabilities; and determining preferred networks based on information within the preferred roaming list including a geographic area and whether the network supports third generation data capabilities, whereby, within the geographic area, the mobile data device prefers networks which support third generation data capabilities over networks which do not support said third generation data capabilities. Other information that may be added to the preferred roaming list includes whether the network supports data roaming, Mobile IP services or always-on features. The preferred roaming list may also include information about the device service capabilities.
Patent EP-1963790-B8 (EP)
Inventor: LOESING KARL-HEINRICH
IPC: G01F1/698
Filed: 2006-12-20
Granted: 2009-08-26
Abstract: The method involves operating the sensor (10) in an operating mode at an operating temperature and switching the sensor over to a cleaning mode to clean the measurement area (32), whereby the cleaning temperature is higher than the operating temperature. The sensor is connected to a controller by which the cleaning mode is activated depending on characteristic data.
Patent EP-1860778-B8 (EP)
Inventor: PEIZERAT ARNAUD
IPC: H03M1/18
Filed: 2007-05-22
Granted: 2009-06-10
Abstract: The sensor has an analog/digital conversion unit with a comparator (130) receiving an analog signal (Vint) of an integration capacitor (110) and delivering an output signal (Scomp) adopting a stable state or another state. A charge injection unit (190) modifies the analog signal by injection of a given charge quantity in the capacitor consecutive to a state change from the stable state to the other state, at an output of the comparator. A charge injection unit control module (250) modifies the quantity based on an intensity of a current (Idet) delivered by a detector (50) e.g. photodiode. An independent claim is also included for a method for controlling a microelectronic device.
Patent BR-PI1002990-B8 (BR)
Title: processo de enriquecimento de vidro bioativo, vidro bioativo enriquecido e uso do mesmo para o preparo de implantes ósseos
Inventor: CELSO APARECIDO BERTRAN
IPC: C03B25/02
Filed: 2010-08-06
Abstract: processo de enriquecimento de vidro bioativo, vidro bioativo enriquecido e uso do mesmo para o preparo de implantes ósseos. a presente invenção se refere a um processo de enriquecimento de vidro bioativo que compreende as etapas de troca iônica (a) e/ou de tratamento térmico (b) . a etapa a compreende a imersão do vidro bioativo em um meio reacional, o qual compreende pelo menos uma fonte de cálcio fundida, sob uma atmosfera inerte e a uma temperatura inferior a temperatura de transição vitrea do dito vidro bioativo. já a etapa b compreende a exposição de pelo menos uma das superfícies do vidro bioativo a uma fonte de calor, por um curto período de tempo e em ciclos repetidos de exposição, em que as demais superfícies do dito vidro bioativo são cobertas por um material isolante térmico. a presente invenção se refere ainda aos vidros bioativos enriquecidos obtidos pelo processo supracitado, bem como, ao uso dos referidos vidros bioativos na preparação de implantes ósseos.
Patent ES-2342530-B8 (ES)
Title: Sistema inteligente de almacenaje de muestras.
Inventor: POCOVI MIERAS MIGUEL
IPC: G06K19/07
Filed: 2008-10-15
Granted: 2011-08-03
Abstract: Sistema inteligente de almacenaje de
muestras. 
     Recipiente que incluye, en una sola
construcción, depósito para muestras y chip RFID (Radio Frequency
IDentification, en español Identificación por radiofrecuencia) que
permite el registro/recuperación de información longitudinal de la
muestra desde un sistema lector/grabador. 
     Este sistema contribuye a establecer un mayor
nivel en la seguridad del contenido de la muestra, permitiendo no
sólo la identificación de la misma sino también posibilitando su
reconocimiento cualitativo a través de la información longitudinal
registrada en el chip RFID. 
     El registro de la información longitudinal en el
propio dispositivo que contiene la muestra, permite disminuir el
tiempo de su manipulación y, en general, el de la ejecución de todos
los protocolos que se establezcan sobre la misma. 
     El dispositivo contiene un chip RFID con un
sistema. emisor/receptor de radiofrecuencia conectable a un sistema
de ordenador mediante cable USB o sistemas de radio Wifi o Bluetooth
con capacidad para operar a -80º centígrados.
Patent AU-2002320114-B8 (AU)
Title: Production of ultrapure bismuth-213 for use in therapeutic nuclear medicine
Inventor: BOND ANDREW H
IPC: G01N30/88
Filed: 2002-06-20
Granted: 2005-09-01
Abstract: A multicolumn selectivity inversion generator has been developed in which bismuth-213 is selectively extracted from an HCl solution of the actinium-225 parent (and its radiogenic descendents) by a primary separation column containing a separation medium containing a neutral oxygenated organophosphorus extractant. After rinsing with dilute HCl, the bismuth-213 is stripped with a buffered NaCl solution. The stripped solution is passed through a cation-exchange resin guard column that retains the actinium-225 and radium-225 contaminants while the bismuth-213 elutes. This generator method minimizes the unpredictable effects of radiation damage to the support material and permits the reliable production of bismuth-213 of high chemical and radionuclidic purity.
Patent AU-2002327268-B8 (AU)
Title: Novel glyphosate-tolerant 5-enolpyruvylshikimate-3-phosphate synthase and the gene encoding the same
Inventor: LIN MIN
IPC: C12N15/09
Filed: 2002-08-05
Granted: 2006-12-14
Abstract: The invention relates to a novel 5-enolpyruvyl-shikimate-3-phosphate synthase (EPSPS). It is highly tolerant to glyphosate, the competitive inhibitor of the substrate phosphoenolpyruvate (PEP). The invention also relates to a gene encoding the synthase, a construct and a vector comprising said gene, and a host cell transformed with said construct or vector.
Patent AU-2006335682-B8 (AU)
Title: Conformable ballistic resitant and protective composite materials composed of shear thickening fluids reinforced by fillers such as fibers
Inventor: NORMAN WAGNER
IPC: B32B3/00
Filed: 2006-02-09
Granted: 2011-08-18
Abstract: A composition which contains a mixture of a shear thickening fluid and at least one inert filler and said shear thickening fluid and filler remain in a conformable form.
Patent BR-112015031174-B8 (BR)
Title: processo em fase gasosa para a preparação de butadieno
Inventor: ANDREI-NICOLAE PARVULESCU
IPC: B01J29/89
Filed: 2014-06-13
Abstract: a presente invenção diz respeito a um processo de fase gasosa para a preparação de butadieno compreendendo (i) prover uma corrente de gás g-1 compreendendo etanol; (ii) colocar a corrente de gás g-1 compreendendo etanol em contato com um catalisador, obtendo, por meio disso, uma corrente de gás g-2 compreendendo butadieno, em que o catalisador compreende um material zeolítico com uma estrutura em treliça compreendendo yo2, y valendo para um ou mais elementos tetravalentes, em que pelo menos uma porção de y compreendida na estrutura em treliça é substituída de maneira isomorfa por um ou mais elementos x, assim como diz respeito a um material zeolítico com uma estrutura em treliça yo2, y estando para um ou mais elementos tetravalentes, em que pelo menos uma porção de y compreendida na estrutura em treliça é substituída de maneira isomorfa por um ou mais elementos x, em que o material zeolítico apresenta um padrão de difração de pó de raio x específico. diz respeito, ainda, ao uso desse material.